US Housing Sec. Carson: Remdesivir appears promising as treatment for COVID-19

Ben Carson, Secretary of the US Department of Housing and Urban Development, told Fox Business Network on Friday that Gilead's Remdesivir appears promising as a potential treatment for COVID-19.

Earlier in the day, a University of Chicago hospital participating in an experimental study using Remdesivir to treat severe coronavirus patients said it was seeing rapid recovery in fever and respiratory symptoms.

Market reaction

After rising as much as 16% in premarket trading, Gilead Sciences, Inc (GILD) shares were last seen adding 8.3% on the day at $82.90.